Back | Next |
home / stock / evok / evok message board
Subject | By | Source | When |
---|---|---|---|
Really??? Were you diagnosed recently | THEMASTERS_SON | investorshub | 04/26/2022 9:32:45 PM |
i may or may not make money here | saigai | investorshub | 04/26/2022 4:24:18 PM |
it is building support just above $1. | Hercules1 | investorshub | 04/26/2022 3:45:30 PM |
Having trouble holding 1.00 salayaa | Imarket13 | investorshub | 04/26/2022 2:57:08 PM |
This will hit $2 after hours. Looking for a | Hercules1 | investorshub | 04/26/2022 2:54:46 PM |
,,,,,,,GASTEROPARITIS IS LINKED TO DIABETES..(WEN..MOON??) | THEMASTERS_SON | investorshub | 04/26/2022 2:51:33 PM |
Good dip buy opportunity. FDA granted exclusivity is a | Hercules1 | investorshub | 04/26/2022 2:51:26 PM |
,,,,,,,Any buy under .92 ur fine! | THEMASTERS_SON | investorshub | 04/26/2022 2:41:57 PM |
Keeps dipping. Dip buy was 1.10 lol | Imarket13 | investorshub | 04/26/2022 2:16:46 PM |
well i donated today...hopefully to someone who needed it | saigai | investorshub | 04/26/2022 2:07:12 PM |
excellent dip buy opportunity. | Hercules1 | investorshub | 04/26/2022 1:58:24 PM |
Damn | Awl416 | investorshub | 04/26/2022 12:46:02 PM |
News | Awl416 | investorshub | 04/26/2022 12:30:52 PM |
whytestocks: $EVOK News Article - Evoke Pharma Announces Approval of GIMOTI to the Texas Medicaid Pr | whytestocks | investorshangout | 04/19/2022 2:40:52 PM |
whytestocks: $EVOK News Article - Evoke Pharma Inc. Looks to Continue to Trade Above its Annual-High | whytestocks | investorshangout | 04/07/2022 4:55:50 PM |
What drove this close to six dollars a | Cuppy | investorshub | 03/21/2022 12:39:53 PM |
Anti-COVID nasal spray could protect against infection for | Adw20mri | investorshub | 01/12/2022 6:33:15 PM |
znewcar1: EVOK 26% v2,3M c.7599 f32,6M H.84 | znewcar1 | investorshangout | 12/10/2021 2:43:52 AM |
znewcar1: EVOK 19% v18,2M c1.34 f32,3M H1.58 S1.3 | znewcar1 | investorshangout | 08/14/2021 4:00:00 AM |
Makin money today! | fishhunter | investorshub | 08/13/2021 8:11:15 PM |
News, Short Squeeze, Breakout and More Instantly...
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily o...
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that its abstra...
114% year-over-year increase in net product sales 70% prescriber growth in Q1 2024 compared to Q4 2023 Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a ...